Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, California, USA.
Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, California, USA.
J Virol. 2014 Jun;88(12):6751-61. doi: 10.1128/JVI.03355-13. Epub 2014 Apr 2.
High-risk types of human papillomavirus (HPV) are the causative agents of virtually all cases of cervical cancer and a significant proportion of other anogenital cancers, as well as both oral and pharyngeal cancers. The high-risk types encode two viral oncogenes, E6 and E7, which work together to initiate cell transformation. Multiple steps involving the activities and interactions of both viral and cellular proteins are involved in the progression from HPV infection to cell transformation to cancer. The E6 oncoprotein is expressed as several isoforms: a full-length variant referred to as E6 and a few shorter isoforms collectively referred to as E6*. In this study, we found that expression of E6* increased the level of reactive oxygen species (ROS) in both HPV-positive and HPV-negative cells. This increased oxidative stress led to higher levels of DNA damage, as assessed by the comet assay, quantification of 8-oxoguanine, and poly(ADP-ribose) polymerase 1. The observed increase in ROS may be due to a decrease in cellular antioxidant activity, as we found that E6* expression also led to decreased expression of superoxide dismutase isoform 2 and glutathione peroxidase. These studies indicate that E6* may play an important role in virus-induced mutagenesis by increasing oxidative stress and DNA damage.
Our findings demonstrate for the first time that an HPV gene product, E6*, can increase ROS levels in host cells. This ability may play a significant role both in the viral life cycle and in cancer development, because an increase in oxidative DNA damage may both facilitate HPV genome amplification and increase the probability of HPV16 DNA integration. Integration, in turn, is thought to be an important step in HPV-mediated carcinogenesis.
人乳头瘤病毒(HPV)的高危型是几乎所有宫颈癌病例以及相当一部分其他生殖器癌症、口腔癌和咽癌的致病因素。高危型 HPV 编码两种病毒癌基因,E6 和 E7,它们协同作用启动细胞转化。从 HPV 感染到细胞转化再到癌症,涉及多个步骤,其中包括病毒和细胞蛋白的活性和相互作用。E6 癌蛋白表达为几种亚型:全长变体称为 E6 和几个较短的亚型统称为 E6*。在这项研究中,我们发现 E6的表达增加了 HPV 阳性和 HPV 阴性细胞中的活性氧(ROS)水平。这种增加的氧化应激导致 DNA 损伤水平升高,如彗星试验、8-氧鸟嘌呤的定量和多聚(ADP-核糖)聚合酶 1 评估所示。观察到的 ROS 增加可能是由于细胞抗氧化活性降低所致,因为我们发现 E6表达也导致超氧化物歧化酶 2 同工型和谷胱甘肽过氧化物酶的表达降低。这些研究表明,E6*可能通过增加氧化应激和 DNA 损伤在病毒诱导的突变中发挥重要作用。
我们的研究结果首次表明,HPV 基因产物 E6*可以增加宿主细胞中的 ROS 水平。这种能力在病毒生命周期和癌症发展中可能都起着重要作用,因为氧化 DNA 损伤的增加既可以促进 HPV 基因组扩增,又可以增加 HPV16 DNA 整合的可能性。反过来,整合被认为是 HPV 介导的致癌作用的一个重要步骤。